We have previously proposed that miR-101 regulates EZH2 expression in CLL, since we showed that silencing or overexpression of miR-101 in primary CLL cells leads to overexpression and downregulation of EZH2 protein expression, respectively [15]. The gene discussed is EZH2; the disease is B-cell chronic lymphocytic leukemia.